Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Inks deal with top 10 big pharma and will provide manufacturing support from facility in Kaysersberg, France.
January 28, 2022
By: Tim Wright
Editor-in-Chief, Contract Pharma
Global contract development and manufacturing organization (CDMO), Recipharm, has inked a deal with a top 10 big pharma company to support vaccine manufacturing from its facility in Kaysersberg, France. The agreement was announced following the successful quality audit and will see Recipharm aseptically pack single-use vaccines, used to treat a severe infectious disease that affects both young children and infants. The containers will be filled using Recipharm’s blow-fill-seal (BFS) capabilities, creating products that are quick to distribute and simplifying administration for healthcare providers. Recipharm plans to recruit over 30 members of staff between 2022 and 2026 as the product scales towards commercial production. “We are very proud to be supporting a big pharma partner in the delivery of a vital vaccine to the market,” said Yves Buelens, general manager at Recipharm’s facility in Kaysersberg. “This deal is indicative of Recipharm’s successful and ongoing product portfolio diversification. We’ve invested heavily into new capabilities that have built on our BFS expertise and as a result, strengthened our biotech offering. We are now in a position to welcome new biopharma projects to the Kaysersberg site.” Recipharm is investing almost €14 million into its vaccine manufacturing offering at the site. Located in the Alsace region of France, Kaysersberg is one of Recipharm’s specialist sterile manufacturing facilities which had been previously dedicated to the exclusive production of sterile liquids for therapeutic areas, including eye care and ear drops. This facility has been inspected and approved by multiple regulatory agencies across the globe including ANSM (EU-GMP), FDA and Brazil’s ANVISA. It also holds a number of approvals for its environmental management systems and occupational health and safety management system.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !